Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2017) 6 P041 | DOI: 10.1530/boneabs.6.P041

ICCBH2017 Poster Presentations (1) (209 abstracts)

A randomised double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using high resolution peripheral quantitative computed tomography

Juliane Paupitz , Glauce Lima , Nadia Aikawa , Jackeline Alvarenga & Rosa Pereira

Faculdade de Medicina Universidade de São Paulo, São Paulo, Brazil.

Objectives: Vitamin D has an important effect on bone but there are no trials that directly address the boosting of serum levels of 25-hydroxyvitamin D (25OHD) in bone microarchitecture in Juvenile-onset Systemic Lupus patients (JoSLE). The aim of this study was to evaluate the effect of vitamin D supplementation on bone microarchitecture parameters using HR-pQCT in JoSLE patients.

Methods: This study was a randomized double-blind placebo-controlled 24-week trial (Clinical Trial Registry NCT01892748) conducted at the Hospital das Clínicas da Universidade de Sao Paulo, Brazil. Forty female JoSLE patients were randomized (1:1) to receive oral cholecalciferol 50,000 IU/week (JoSLE-VitD) or placebo (JoSLE-PL). Medications remained stable throughout the study. Serum levels of 25OHD were measured using radioimmunoassay. Bone microarchitecture and volumetric bone density were analysed using HR-pQCT at tibia site.

Results: At baseline, groups were similar regarding age, BMI, organ involvement, glucocorticoid dose, immunosuppressant use, serum levels of 25OHD and HR-pQCT parameters. After 24 weeks, higher 25OHD levels were observed in the JoSLE-VitD group compared to the JoSLE-PL [31.3(8.6) vs. 16.5(5.8) ng/ml, P<0.001]. An increase in trabecular number [ΔTb.N: 0.16(0.24) vs. 0.03(0.19), P=0.024] and a decrease in trabecular separation [ΔThSp: -0.045(0.067) vs. 0.001(0.009), P=0.017] were found in JoSLE-VitD group than in JoSLE-PL at tibia site. No differences were observed in other structural parameters [trabecular (Tb.Th) or cortical thickness (Ct.Th)], volumetric bone mineral densities, cortical porosity and biomechanical parameters (P>0.05).

Conclusion: This study suggests that cholecalciferol supplementation for 24 weeks could be effective in improving bone microarchitecture parameters, mainly trabecular number in JoSLE patients. The authors have declared no conflicts of interest

Disclosure: The authors declared no competing interests.

Volume 6

8th International Conference on Children's Bone Health


Browse other volumes

Article tools

My recent searches

No recent searches.